Cite
Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity.
MLA
Siejka, Agnieszka, et al. “Reduced Plasma Level of Diazepam-Binding Inhibitor (DBI) in Patients with Morbid Obesity.” Endocrine, vol. 49, no. 3, Aug. 2015, pp. 859–62. EBSCOhost, https://doi.org/10.1007/s12020-014-0522-5.
APA
Siejka, A., Jankiewicz-Wika, J., Stępień, H., Fryczak, J., Świętosławski, J., & Komorowski, J. (2015). Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity. Endocrine, 49(3), 859–862. https://doi.org/10.1007/s12020-014-0522-5
Chicago
Siejka, Agnieszka, Joanna Jankiewicz-Wika, Henryk Stępień, Jolanta Fryczak, Jacek Świętosławski, and Jan Komorowski. 2015. “Reduced Plasma Level of Diazepam-Binding Inhibitor (DBI) in Patients with Morbid Obesity.” Endocrine 49 (3): 859–62. doi:10.1007/s12020-014-0522-5.